Cellectar Biosciences, Inc. (CLRB)
2.95
+0.21
(+7.66%)
USD |
NASDAQ |
Dec 31, 16:00
2.90
-0.05
(-1.69%)
After-Hours: 20:00
Cellectar Biosciences EPS Diluted (Quarterly): -1.405 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Imunon, Inc. | -1.165 |
| PDS Biotechnology Corp. | -0.1922 |
| PAVmed, Inc. | -0.2936 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.444M |
| Total Expenses (Quarterly) | 4.444M |
| Enterprise Value | -4.874M |
| Earnings Yield | -219.3% |
| Normalized Earnings Yield | -386.45 |